论文部分内容阅读
目的:探析重症肺炎运用硫酸依替米星联合抗菌药物治疗的临床效果。方法:选择2014年2月-12月期间我院收治的重症肺炎患者62例为研究对象,随机分为两组,其中给予对照组常规治疗,而观察组则运用硫酸依替米星和抗菌药物联合治疗,对比分析两组的治疗效果。结果:经过10d治疗,观察组的治疗总有效率明显高于对照组,并且与对照组相比,观察组的细菌清除率和不良反应发生率均较低,组间比较有统计学意义(P<0.05)。结论:临床上运用硫酸依替米星和抗菌药物联合治疗重症肺炎,不仅不良反应少、安全性高、治疗效果好,还能提高细菌清除率,改善患者预后。
Objective: To investigate the clinical effect of using etimicin sulfate and antibacterials in the treatment of severe pneumonia. Methods: Sixty-two patients with severe pneumonia admitted in our hospital from February to December 2014 were selected and divided into two groups at random. The patients in the observation group were treated with eptifibatide and antimicrobial agents Combined treatment, comparative analysis of two groups of treatment. Results: After 10 days of treatment, the total effective rate of the observation group was significantly higher than that of the control group, and the bacterial clearance rate and incidence of adverse reactions in the observation group were lower than those in the control group (P <0.05). Conclusion: The clinical use of etimicin sulfate and antibacterial drugs in the treatment of severe pneumonia is not only less adverse reactions, high safety, good therapeutic effect, but also improve bacterial clearance and improve prognosis.